Skip to main content

Table 2 Adverse Events

From: Long term follow-up of neoadjuvant chemotherapy for non-small cell lung cancer (NSCLC) investigating early positron emission tomography (PET) scan as a predictor of outcome

Toxicity Category Grade Number (%)
Fatigue 3 7 (28)
Pain 3 2 (8)
Metabolic/Laboratory 3 1 (4)
Pulmonary 3 3 (12)
Gastrointestinal 3 4 (16)
Dermatologic/skin 3 2 (8)
Neurologic 4 1 (4)
Allergy/Immunologic 3 1 (4)
  1. Note: Maximum grade per patient per body system presented. Number of evaluable patients: 25. Total number of patients with grade 3/4 toxicities: 10 (patients with multiple toxicities and are listed separately above)